Results
|
|
981.
|
|
|
|
982.
|
|
|
|
983.
|
|
|
|
984.
|
|
|
|
985.
|
|
|
|
986.
|
Optimization beyond AMG 232: discovery and SAR of sulfonamides on a piperidinone scaffold as potent inhibitors of the MDM2-p53 protein-protein interaction. [electronic resource] by
- Wang, Yingcai
- Zhu, Jiang
- Liu, Jiwen Jim
- Chen, Xiaoqi
- Mihalic, Jeff
- Deignan, Jeffrey
- Yu, Ming
- Sun, Daqing
- Kayser, Frank
- McGee, Lawrence R
- Lo, Mei-Chu
- Chen, Ada
- Zhou, Jing
- Ye, Qiuping
- Huang, Xin
- Long, Alexander M
- Yakowec, Peter
- Oliner, Jonathan D
- Olson, Steven H
- Medina, Julio C
Producer: 20150306
In:
Bioorganic & medicinal chemistry letters vol. 24
Availability: No items available.
|
|
|
987.
|
|
|
|
988.
|
|
|
|
989.
|
|
|
|
990.
|
Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier. [electronic resource] by
- Carpio, Cecilia
- Bouabdallah, Reda
- Ysebaert, Loïc
- Sancho, Juan-Manuel
- Salles, Gilles
- Cordoba, Raul
- Pinto, Antonio
- Gharibo, Mecide
- Rasco, Drew
- Panizo, Carlos
- Lopez-Martin, Jose A
- Santoro, Armando
- Salar, Antonio
- Damian, Silvia
- Martin, Alejandro
- Verhoef, Gregor
- Van den Neste, Eric
- Wang, Maria
- Couto, Suzana
- Carrancio, Soraya
- Weng, Andrew
- Wang, Xuehai
- Schmitz, Frank
- Wei, Xin
- Hege, Kristen
- Trotter, Matthew W B
- Risueño, Alberto
- Buchholz, Tonia J
- Hagner, Patrick R
- Gandhi, Anita K
- Pourdehnad, Michael
- Ribrag, Vincent
Producer: 20201020
In:
Blood vol. 135
Availability: No items available.
|
|
|
991.
|
|
|
|
992.
|
|
|
|
993.
|
The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. [electronic resource] by
- Gaster, L M
- Ham, P
- Joiner, G F
- King, F D
- Mulholland, K R
- Wyman, P A
- Hagan, J J
- Price, G W
- Roberts, C
- Routledge, C
- Selkirk, J
- Slade, P D
- Middlemiss, D N
Producer: 19990225
In:
Annals of the New York Academy of Sciences vol. 861
Availability: No items available.
|
|
|
994.
|
|
|
|
995.
|
|
|
|
996.
|
A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes. [electronic resource] by
- Rhee, E J
- Lee, W Y
- Yoon, K H
- Yoo, S J
- Lee, I K
- Baik, S H
- Kim, Y K
- Lee, M K
- Park, K S
- Park, J Y
- Cha, B S
- Lee, H W
- Min, K W
- Bae, H Y
- Kim, M J
- Kim, J A
- Kim, D K
- Kim, S W
Producer: 20110603
In:
Diabetes, obesity & metabolism vol. 12
Availability: No items available.
|
|
|
997.
|
Evaluation of the pharmacokinetics of the DPP-4 inhibitor gemigliptin when coadministered with rosuvastatin or irbesartan to healthy subjects. [electronic resource] by
- Choi, Hee Youn
- Lim, Hyeong-Seok
- Kim, Yo Han
- Jeon, Hae Sun
- Kim, Mi Jo
- Lee, Shi Hyang
- Jung, Jong Hyuk
- Lee, Young Kyoung
- Kim, Hyun Jeong
- Bae, Kyun-Seop
Producer: 20150729
In:
Current medical research and opinion vol. 31
Availability: No items available.
|
|
|
998.
|
|
|
|
999.
|
|
|
|
1000.
|
KBH-A42, a histone deacetylase inhibitor, inhibits the growth of doxorubicin-resistant leukemia cells expressing P-glycoprotein. [electronic resource] by
- Kang, Moo Rim
- Lee, Kiho
- Kang, Jong Soon
- Lee, Chang Woo
- Lee, Ki Hoon
- Kim, Jang Hyun
- Yang, Jeong Wook
- Kim, Bo Geun
- Han, Gyoonhee
- Kang, Jong Seong
- Park, Song-Kyu
- Kim, Hwan Mook
Producer: 20100429
In:
Oncology reports vol. 23
Availability: No items available.
|